EU antitrust regulators are set to grant conditional clearance to German health group Siemens Healthineers’ US$16.4-billion bid for US peer Varian Medical Systems, reported Reuters.
The EU green light will come after Siemens Healthineers last month offered concessions to address competition concerns about interoperability, the sources said. Such a measure enables computer systems and software to work with each other.
The acquisition seeks to create a multi-disciplinary healthcare company with a comprehensive cancer care portfolio. The transaction is expected to close in the first half of this year. In October last year, Varian shareholders had also approved the transaction.
Varian is a developer of oncology care technologies and solutions while Siemens Healthineers is a medical technology company whose portfolio includes imaging and diagnostic systems and advanced therapy systems including angiography systems and computed tomography (CT) systems.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Canada Targets Tech Titans with New Digital Tax in 2024
Apr 17, 2024 by
CPI
EU Privacy Watchdog Calls for Meta to Offer Ad-Free Option
Apr 17, 2024 by
CPI
Japan’s Antitrust Overhaul Targets Tech Titans Like Apple
Apr 17, 2024 by
CPI
Ryanair to Amplify Italian Presence Despite Antitrust Issues
Apr 17, 2024 by
CPI
FTC to Vote on Ban on Noncompete Clauses in Employment Contracts
Apr 17, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – China Edition – Year of the Dragon
Apr 16, 2024 by
CPI
Review Logic and Rules for Concentrations of Undertakings that Do Not Meet the Standard of Notification
Apr 16, 2024 by
CPI
China’s Review of Semiconductor Transactions
Apr 16, 2024 by
CPI
Key Challenges and Tips for Merger Control Filing in China for Listed Companies
Apr 16, 2024 by
CPI
Key Point Review: China SPC Antitrust Judgments in 2023
Apr 16, 2024 by
CPI